Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Bukwang Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	104,096	96,208	90,091	151,227	85,517	82,777
Short-Term Investments	65,000	120,000	40,000	-	-	1,500
Cash & Short-Term Investments	169,096	216,208	130,091	151,227	85,517	84,277
Cash Growth	21.14%	66.20%	-13.98%	76.84%	1.47%	-5.93%
Accounts Receivable	30,839	27,845	23,559	35,729	87,950	90,428
Other Receivables	4,466	1,835	994.31	1,647	360.04	2,413
Receivables	40,306	29,681	24,553	37,376	88,310	92,842
Inventory	53,194	52,205	41,667	56,832	38,607	39,294
Prepaid Expenses	250.94	223.5	398.29	166.97	173.46	205.7
Other Current Assets	3,506	4,860	7,030	8,576	6,134	3,476
Total Current Assets	266,353	303,177	203,739	254,179	218,741	220,095
Property, Plant & Equipment	147,322	144,985	141,481	122,789	123,960	124,531
Long-Term Investments	16,216	15,683	16,775	31,626	35,132	36,963
Goodwill	-	-	406.62	878.73	834.51	828.7
Other Intangible Assets	6,578	5,052	5,868	9,177	6,157	6,151
Long-Term Deferred Tax Assets	-	-	-	-	-	3.63
Other Long-Term Assets	30,580	7,397	4,910	10,368	16,105	8,843
Total Assets	467,049	476,295	373,180	429,017	400,929	397,417

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	11,593	7,297	5,062	2,368	16,530	7,421
Accrued Expenses	-	2,579	1,907	2,978	1,755	1,776
Current Portion of Long-Term Debt	79,818	79,532	-	-	-	-
Current Portion of Leases	428.81	295.3	130.19	217.6	242.91	444.17
Current Income Taxes Payable	-	-	-	357.47	4,312	3,996
Other Current Liabilities	22,385	28,115	28,299	91,622	21,764	23,358
Total Current Liabilities	114,225	117,818	35,398	97,544	44,603	36,995
Long-Term Debt	-	-	79,024	78,525	-	-
Long-Term Leases	421.12	513.55	269.91	644.17	687.88	1,114
Long-Term Deferred Tax Liabilities	17,595	16,615	13,917	10,068	11,011	11,217
Other Long-Term Liabilities	416.55	416.55	425.12	7,971	72,780	68,030
Total Liabilities	132,657	135,363	129,035	194,752	129,082	117,356

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	51,507	51,507	36,402	36,402	36,402	36,402
Additional Paid-In Capital	85,518	85,518	12,452	4,808	6,800	7,357
Retained Earnings	168,400	173,433	166,822	225,783	258,585	264,703
Treasury Stock	-	-	-	-50,784	-50,784	-50,784
Comprehensive Income & Other	28,709	30,142	28,000	10,103	12,215	11,930
Total Common Equity	334,134	340,600	243,676	226,311	263,217	269,608
Minority Interest	258.16	332.14	469.85	7,953	8,630	10,453
Shareholders' Equity	334,392	340,932	244,146	234,265	271,847	280,061
Total Liabilities & Equity	467,049	476,295	373,180	429,017	400,929	397,417

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	80,667	80,341	79,424	79,387	930.79	1,558
Net Cash (Debt)	88,429	135,867	50,667	71,840	84,586	82,719
Net Cash Growth	49.01%	168.16%	-29.47%	-15.07%	2.26%	21.57%
Net Cash Per Share	904.56	1644.73	740.15	1049.46	1235.65	1208.27
Filing Date Shares Outstanding	98.66	98.66	68.45	68.45	68.45	68.45
Total Common Shares Outstanding	98.66	98.66	68.45	68.45	68.45	68.45
Working Capital	152,128	185,360	168,341	156,634	174,138	183,101
Book Value Per Share	3386.56	3452.10	3559.67	3306.00	3845.13	3938.48
Tangible Book Value	327,556	335,548	237,401	216,255	256,226	262,628
Tangible Book Value Per Share	3319.89	3400.89	3468.00	3159.10	3743.01	3836.52
Land	112,939	112,939	113,314	92,875	92,875	92,875
Buildings	52,391	52,274	51,499	51,450	50,602	50,602
Machinery	50,993	47,785	49,276	48,406	48,080	46,343
Construction In Progress	319.53	527.8	311.17	-	76.21	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 17, 2026

Data Sources Report a data error